Drug Interactions between carvedilol and Januvia
This report displays the potential drug interactions for the following 2 drugs:
- Januvia (sitagliptin)
Interactions between your drugs
No interactions were found between carvedilol and Januvia. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Carvedilol is in the drug class non-cardioselective beta blockers.
- Carvedilol is used to treat the following conditions:
- Januvia is in the drug class dipeptidyl peptidase 4 inhibitors.
- Januvia is used to treat Diabetes, Type 2.
Drug and food interactions
Applies to: Januvia (sitagliptin)
Alcohol may affect blood glucose levels in patients with diabetes. Both hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) may occur, depending on how much and how often you drink. You should avoid using alcohol if your diabetes is not well controlled or if you have high triglycerides, neuropathy (nerve damage), or pancreatitis. Moderate alcohol consumption generally does not affect blood glucose levels if your diabetes is under control. However, it may be best to limit alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with your normal meal plan. Avoid drinking alcohol on an empty stomach or following exercise, as it may increase the risk of hypoglycemia. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
|No interaction information available.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.